Q BioMed Inc. Announces Entry Into Definitive Funding Agreement for up to $4,000,000 Capital injection provides runway to bring FDA approved cancer palliation drug to market in early 2017 and continue advancing our glaucoma drug

NEW YORK, November 30, 2016 /PRNewswire/ — Q BioMed Inc. (OTCQB: QBIO), is pleased to announce that it has entered into a definitive agreement with Yorkville Advisors Global (“Yorkville”) for up to $4,000,000 of convertible debentures. We have closed...